Synergism of FAK and ROS1 inhibitors in the treatment of <i>CDH1</i>-deficient cancers mediated by FAK-YAP signaling
Jiaming Gao, Yunying Yao, Chenxuan Liu, Xie Xi, Donghe Li, Ping Liu, Zaiqi Wang, Baoyuan Zhang, Ruibao Ren
Abstract
-deficient triple negative breast cancer and diffuse gastric cancer patients.
Topics & Concepts
CDH1Cancer researchCancerCancer cellROS1CytotoxicityBreast cancerMedicineBiologyCellInternal medicineAdenocarcinomaBiochemistryIn vitroCadherinHippo pathway signaling and YAP/TAZWnt/β-catenin signaling in development and cancerUbiquitin and proteasome pathways